Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TNF | P01375 | 2/20 | 0.42 |
| ▸ | DYRK1A | Q13627 | 2/20 | 0.34 |
| ▸ | CYP17A1 | P05093 | 4/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
| ▸ | CDC7 | O00311 | 1/20 | 0.32 |
| ▸ | CDK2 | P24941 | 1/20 | 0.32 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.32 |
| ▸ | HTR6 | P50406 | 1/20 | 0.32 |
| ▸ | MAOA | P21397 | 4/20 | 0.32 |
| ▸ | MAOB | P27338 | 4/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | CSNK2A2 | P19784 | 2/20 | 0.31 |
| ▸ | CSNK2B | P67870 | 2/20 | 0.31 |
| ▸ | TOP2A | P11388 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21473093 | 1.00 | TNF (0.42) | TNFDYRK1ACYP17A1CYP1A2KCNH2 | |
| SCHEMBL21473074 | 0.89 | TNF (0.38) | TNFDYRK1ACYP17A1CYP1A2IMPDH2 | |
| SCHEMBL21461880 | 0.89 | MAPK14 (0.34) | HTR6 | |
| SCHEMBL21472987 | 0.86 | CDK4 (0.35) | CYP1A2HTR6 | |
| SCHEMBL21473101 | 0.83 | MEN1 (0.34) | — | |
| SCHEMBL21473034 | 0.81 | TOP1 (0.33) | — | |
| SCHEMBL21473102 | 0.81 | TOP1 (0.33) | — | |
| SCHEMBL21472988 | 0.81 | PRKDC (0.33) | MAOB | |
| SCHEMBL21473035 | 0.80 | GABRP (0.32) | — | |
| SCHEMBL21473107 | 0.80 | PLG (0.33) | CDK2TOP2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190315759-A1 | HOST MATERIALS FOR ELECTROLUMINESCENT DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2019-10-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190315759-A1 | HOST MATERIALS FOR ELECTROLUMINESCENT DEVICES | OSBP, OSBP2, OSBPL3 | TNF 4748/4885DYRK1A 4816/4885CYP17A1 2489/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.